1102 ECP IgGenix
BioCentury & Getty Images

Emerging Company Profile

IgGenix: antibody engineering for food allergies

IgGenix is blocking the inflammatory response in food allergies with redesigned antibodies

IgGenix is designing a new type of food allergy therapy by reprogramming how allergenic antibodies interact with the immune system.

Nov 7, 2020 | 2:46 AM GMT

IgGenix is pairing single-cell sequencing with antibody engineering to create a new class of food allergy therapies that selectively suppresses allergen-triggered immunity while sidestepping the risky steps

Read the full 770 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers